SARS-CoV-2, the autoimmune virus

G. Halpert, Y. Shoenfeld,

2021

https://doi.org/10.1016/j.autrev.2020.102695

Цитирование

Об авторах

G. Halpert
Zabludowicz Center for Autoimmune Diseases, Sheba Medical Center, Tel-Hashomer, Ramat-Gan, 52621, Israel
Y. Shoenfeld
Laboratory of the Mosaic of Autoimmunity, Saint Petersburg State University, Saint-Petersburg, 199034, Russian Federation

Название журнала

Том

Выпуск

Страницы

Ключевые слова

angiotensin converting enzyme 2; antinuclear antibody; enzyme antibody; interferon antibody; interferon induced helicase C domain containing protein 1; phospholipid antibody; protein antibody; SARS-CoV-2 vaccine; ACE2 protein, human; autoantibody; HLA antigen; anosmia; autoimmune disease; coronavirus disease 2019; cytokine storm; DNA polymorphism; Editorial; HLA system; human; hyperferritinemia; immunostimulation; Severe acute respiratory syndrome coronavirus 2; autoimmune disease; complication; cytokine release syndrome; genetics; immunology; pathogenicity; Angiotensin-Converting Enzyme 2; Anosmia; Autoantibodies; Autoimmune Diseases; COVID-19; COVID-19 Vaccines; Cytokine Release Syndrome; HLA Antigens; Humans; Hyperferritinemia; SARS-CoV-2

Издатель

Тип документа

Тип лицензии Creative Commons

Правовой статус документа

Источник